Newsletters

This page contains an archive of our research area specific eNewsletters. If you would like to be kept up to date on new products, promotions, and up and coming events, sign up to receive Novus eNews. Create a new account here, or if you already have an account, login and click on Profile.

The Affinity Binder Knockdown Initiative

Novus Biologicals, a Bio-techne brand, is excited to announce our renewed support of the Affinity Binder Knockdown Initiative.

Started in 2015, the Affinity Binder Knockdown Initiative is supported by the European Proteomics Association (EuPA) and the Human Proteome Organization (HUPO). Established under the aegis of Antibodypedia, a publicly available online resource established to allow sharing and comparison of antibody validation data, the Knockdown Initiative provides a systematic platform for handling of data in a...

20% Off IHC Slides and Support Products

Do you have a need for tissue slides and reagents such as citrate buffer and chromogen for your Immunohistochemistry (IHC) experiments? Novus Biologicals is offering a 20% discount on

Novus offers anti-FGF R1 mouse monoclonal antibody (clone: M17A3) [NB100-2079], a powerful tool to help advance your cell signaling research. This antibody is available in unconjugated form as well as in

Mouse monoclonal Melan-A/MART-1 antibody (clone A103) is a great tool in histopathology and it was originally developed for the detection of malignant melanoma in paraffin-embedded tissue sections. Currently, it is an emerging target in melanoma research with applications well beyond histopathology, especially in immunotherapy. Novus Biologicals offers this product in its unconjugated form as well as on


Clone M1/70.15 is one of the most popular options for CD11b antibodies, and Novus Biologicals offers this product in its unconjugated form as well as on 18 directly conjugated formats (16 fluorochromes) to meet your Flow Cytometry /Immunostaining needs. This antibody has been cited in multiple research publications and its brief summary is as follows:

...

TARGET SUMMARY

 

Pages